Global review of bladder cancer combo therapy launches
Knowledge-focused
Not yet recruiting
This study will collect and analyze data from 361 patients worldwide who received a combination of two drugs (enfortumab vedotin and pembrolizumab) as their first treatment for advanced or metastatic bladder cancer. The goal is to see how long patients live and how well the treat…
Sponsor: Aron Research Foundation Ets • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC